Subscribe Sign In Register

Premium

ValueAct’s Big Year Continues With Third-Quarter Gains

The sometime-activist is on pace to post its best results in six years.

By Stephen Taub Stephen Taub
October 7, 2019
An Olympus Medical Systems LED endoscope. (Tomohiro Ohsumi/Bloomberg)

An Olympus Medical Systems LED endoscope.

(Tomohiro Ohsumi/Bloomberg)

Jeff Ubben’s ValueAct Capital extended its gains in the third quarter in both of its main funds after enjoying a strong first half.

The ValueAct Master Fund rose 1.3 percent in the September period, boosting its gain for the year to 22.2 percent, according to an investor.

To continue reading, subscribe now to Premium Journalism. Already a subscriber? login.

Related
Background of international currency notes
Sponsored
How Do FX Markets Respond to U.S. Rate Cuts?
Golden pipes going to oil refinery
Sponsored
What Do Diesel and Gasoline Tell us About Oil Prices?
Modern Data Technology Center Server Racks in Dark Room with VFX. Visualization Concept of Internet of Things, Data Flow, Digitalization of Internet Traffic. Electric Equipment Warehouse.
Sponsored
The Future of Data Centers: Trends, Challenges and Real Estate Opportunities